Search Results

The lobbying groups aren't happy about President Donald Trump's plan to borrow from Europe's system of paying for some high-cost drugs.

Ballot measures in two San Francisco Bay Area cities that would limit how much hospitals and doctors can charge for patient care, but do the cities have that authority?

Millennials' preference for convenience, fast service, connectivity and price transparency are upending the traditional office-based primary care model.

A new advocacy group is outspokenly defending high drug prices and criticizing advocates for lower drug prices. Who are they?

Transparency, technology and convenience: any solution that does not address that trio will not contribute to a truly accessible health care system.

Exasperated Maryland officials are presenting hospital cost information in a way they believe Americans might understand: on a T-shirt.

Legislation limiting a provider's ability to negotiate prices could ultimately result in reduced access to care for consumers.

Attendees of the recent Q4Live conference in San Diego discussed realistic and actionable ways to address the quality and cost of their clients' benefits plans.